There may be important differences in the effect different GnRH antagonists can have on bone

There may be important differences in the effect different GnRH antagonists can have on bone – especially if there are different dose strengths available and whether they are used with add-back therapy or not.^1,2

The Summary of Product Characteristics for any available GnRH antagonist clearly shows the incidence of BMD loss, observed in the respective Phase 3 trials^1,2